Abstract
Objective:
Energy drinks (EDs) are widely consumed products of the beverage industry and are often chosen by teenagers and young adults. Several adverse cardiovascular events and malignant cardiac arrhythmias following consumption of EDs have been reported in the literature. Several studies have suggested that the interval from the peak to the end of the electrocardiographic T wave (Tp-e) may correspond to the dispersion of repolarization and that an increased Tp-e interval and Tp-e/QT ratio are associated with malignant ventricular arrhythmias. This study investigated the acute effects of Red Bull ED on ventricular repolarization as assessed by the Tp-e interval and Tp-e/QT ratio.
Methods:
A prospective, open-label study design was used. After an 8-h fast, 50 young, healthy subjects consumed 355 mL of Red Bull ED. The Tp-e interval, Tp-e/QTc ratio, and several other electrocardiographic parameters were measured at baseline and 2 h after ingestion of Red Bull ED.
Results:
No significant changes in the Tp-e interval or Tp-e/QTc ratio were observed with Red Bull ED consumption. Red Bull ED consumption led to increases in both systolic and diastolic blood pressures, which were associated with an increased heart rate.
Conclusion:
Although ingestion of Red Bull ED increases the heart rate and diastolic and systolic blood pressures, it does not cause alterations in ventricular repolarization as assessed by the Tp-e interval and Tp-e/QTc ratio.
Keywords: energy drink, adverse effect, blood pressure, ventricular repolarization, caffeine
Introduction
After multivitamins, energy drinks (EDs) are the most popular dietary supplements in the young adult population (1). EDs constitute a category of sugary drinks that contain variable amounts of caffeine, taurine, glucuronolactone, and other ingredients that may include vitamins and minerals (2). Despite their popularity, there are health concerns about EDs because of reported side effects such as cardiovascular complications. Previous case reports have linked EDs with sudden cardiac death, coronary vasospasm, reversible postural tachycardia syndrome, and serious arrhythmias including ventricular fibrillation (3). Many reports of adverse events linked to ED consumption have been listed in the Federal Drug Administration’s recently released report on EDs, including 18 deaths and 1 nonfatal myocardial infarction (4).
Most adverse effects and toxicities associated with EDs have been attributed to the high caffeine content of EDs (5). Caffeine is a potent stimulant, particularly at high doses (6). Caffeine binds to the G-protein-coupled receptors on the surface of cardiac myocytes, ultimately leading to increases in intracellular cyclic AMP and calcium concentrations, mimicking the chronotropic and inotropic effects of adrenaline. Numerous clinical studies have shown that caffeine induces a temporary elevation in blood pressure and a slight reduction in heart rate (7, 8). EDs also contains high doses of taurine and glucuronolactone. Taurine can have deleterious effects on sodium channels and can cause arrhythmias (9). In addition, a recent study demonstrated that a single dose of a dietary supplement containing ephedra and caffeine resulted in significant prolongation of the QTc interval and P-wave duration, which are risk factors for the development of ventricular and atrial arrhythmias, respectively (10). EDs have also been shown to increase platelet aggregation (11), worsen endothelial function (11), reduce myocardial blood flow when consumed before exercise (12), and significantly increase oxygen demand (13).
Recent studies have shown that the length of the terminal part of the QT interval, defined as the distance between the peak and end of the T wave (Tp-e), is an index of the total spatial dispersion of cardiac repolarization (14). The Tp-e/QT ratio and the Tp-e/QTc ratio are also used as electrocardiographic indices of ventricular arrhythmogenesis (15). To the best of our knowledge, the effect of EDs on the Tp-e/QT and Tp-e/QTc ratios has not been determined. This study investigated the acute effects of Red Bull ED on several commonly used electrocardiographic parameters and ventricular repolarization as assessed by the Tp-e interval and Tp-e/QT ratio in healthy young subjects.
Methods
Study population
The study group comprised 52 healthy young students of Istanbul School of Medicine (mean age: 25±2.3 years). A prospective, open-label study design was used. All subjects had an unremarkable medical history and normal findings on physical examination, electrocardiography, and echocardiography. No subjects were taking any drugs, and no subjects were smokers. Two subjects were usual consumers of EDs (no more than 1 ED per week). Only 5 practiced sports. The characteristics of the study population are reported in Table 1.
Table 1.
Baseline characteristics of the study population
| Study population (n=50) Meaıı±SD | |
|---|---|
| Age, years | 25±2.3 |
| Male sex, % | 30 (60%) |
| Weight, kg | 74.69±6.10 |
| Height, cm | 170.4±4.89 |
| BMI, kg/m2 | 25.6±1.47 |
| LVEF, % | 65.25±6.96 |
| LA diameter, mm | 33.1±3 |
| LVEDV/BSA, mL/m2 | 85.4±9.82 |
| LVESV/BSA, mL/m2 | 35.7±11.4 |
| IVSD, mm | 8.22±0.55 |
| Total cholesterol, mg/dL | 171.67±39.61 |
| Glucose, mg/dL | 94±6.2 |
| Hemoglobin, g/dL | 14.1±2.37 |
| Creatinine, mg/dL | 1.1±0.32 |
| BUN, mg/dL | 15.2±5.8 |
BMI - body mass index; BSA - body surface area; LA - left atrium; LVEDV - left ventricular end-diastolic volume; LVEF - left ventricular ejection fraction; LVESV - left ventricular end-systolic diameter; IVSD - interventricular septum diameter
Written informed consent was obtained from each subject, and the institutional Ethics Committee approved the study protocol.
Study design
All participants abstained from caffeinated products for at least 2 days before study initiation. All experiments took place in a quiet, temperature-controlled (20°C-22°C) laboratory and started between 8:00 am and 9:00 am. After an 8-h fast, all 50 subjects consumed 355 mL of Red Bull ED containing caffeine (114 mg), taurine (1.42 mg), glucuronolactone (84.2 mg), and sucrose and glucose (39.1 g) at room temperature. Baseline 12-lead electrocardiography was performed, and a subsequent 12-lead electrocardiography was performed 1 h and 2 h after ingestion of Red Bull ED.
Electrocardiogram and Tp-e interval measurement
All standard 12-lead electrocardiogram (ECGs) were recorded on digitized 12-lead ECG recordings using the on-screen digital caliper software Cardio Calipers version 3.3 (Iconico, Inc., New York, NY). Twelve-lead electrocardiography was performed before and 1 h and 2 h after consuming the ED. Lead V5 was selected in all ECG recordings for general comparisons of the PR, QRS, QT, and RR intervals.
The Tp-e interval was measured using the tangent method (13). The time (in ms) from the peak of the T wave (or nadir if a negative or biphasic T wave was obtained) and the intersection between the tangent at the steepest point of the T-wave downslope and the isoelectric line was measured. Because previous studies have postulated that precordial leads best reflect transmural dispersion of repolarization and that limb leads best reflect apical-basal or global spatial dispersion, the Tp-e interval was measured from the peak of the T wave to the end of the T wave using the best available T wave in lead V5, a method that has been described previously (14). When V5 was not suitable for analysis leads, V4 and V6 were measured. We used HR-corrected QT and Tp-e using Bazett’s formula that has been used previously in HR correction (n=n/VRR). Subjects with U waves on their ECGs were excluded from the study. Two subjects had U waves and their T-wave amplitude was <1.5 mV on their ECGs and were excluded from the study.
Statistical analyses
All statistical tests were conducted using the Statistical Package for Social Sciences 19.0 for Windows (SPSS Inc., Chicago, IL, USA). The Kolmogorov-Smirnov test was used to analyze the normality of the data. Continuous data are expressed as means±standard deviation and categorical data as percentages. The paired sample t-test was used to assess differences between variables before and after Red Bull ED consumption. Statistical significance was assumed to be present at a 2-sided p value of <0.05.
Results
All 50 volunteers successfully completed the study. The subjects’ baseline characteristics are shown in Table 1. ED did not significantly alter the PR, QRS, QT, QTc, Tp-e, and cTp-e intervals and the Tp-e/QT and Tp-e/QTc ratios compared with baseline (Table 2, 3). However, systolic blood pressure (SBP) increased from 112±6.1 mm Hg at baseline to 123±6.9 mm Hg after 1 h (p=0.003) and 121±7.4 mm Hg after 2 h (p=0.006); diastolic blood pressure (DBP) increased from 73±5.3 mm Hg at baseline to 77.4±6.4 mm Hg after 1 h (p=0.05) and 76.3±6.2 mm Hg after 2 h (p=0.008). The heart rate increased from 77.96±14.94 beats/min at baseline to 83.8±12.1 beats/min after 1 h (p=0.008) and 84.8±10.7 beats/min after 2 h (p=0.005). There was no difference in these parameters between males and females. The interobserver and intraobserver coefficients of variation were 2.5% and 2.8%, respectively.
Table 2.
Heart rate and electrocardiographic and blood pressure parameters before and after 1 h of energy drink (ED) consumption
| Before ED Mean±SD (ıı=50) | After 1 h of ED consumption Mean±SD (n=50) | P | |
|---|---|---|---|
| Heart rate, bmp | 77.96±14.94 | 83.8±12.1 | 0.008 |
| Systolic BP mm Hg | 112±6.1 | 123±6.9 | 0.003 |
| Diastolic BP mm Hg | 73±5.3 | 77.4±6.4 | 0.005 |
| PR interval, ms | 167.2±26.1 | 170±26.3 | 0.9 |
| QRS duration, ms | 90.5±9.7 | 94±10.4 | 0.7 |
| QT interval, ms | 384.1±14.3 | 387±12.6 | 0.37 |
| QTc interval, ms | 406.4±20.6 | 418±23.4 | 0.3 |
| Tp-e, ms | 67.3±15.9 | 69.2±15.8 | 0.44 |
| cTp-e, ms | 69.3±16.8 | 72±15.2 | 0.5 |
| Tp-e/QT | 0.17±0.03 | 0.18±0.04 | 0.47 |
| Tp-e/QTc | 0.16±0.02 | 0.17±0.02 | 0.41 |
BP - blood pressure; bmp - beats/minute; ms - milliseconds; Tp-e - distance between the peak and the end of the T wave
Table 3.
Heart rate and electrocardiographic and blood pressure parameters before and after 2 h of energy drink (ED) consumption
| Before ED Mean±SD (n=50) | After 2 h ED Mean±SD (n=50) | P | |
|---|---|---|---|
| Heart rate, bmp | 77.96±14.94 | 84.8±10.7 | 0.005 |
| Systolic BP mm Hg | 112±6.1 | 121±7.4 | 0.006 |
| Diastolic BP mm Hg | 73±5.3 | 76.3±6.2 | 0.008 |
| PR interval, ms | 167.2±26.1 | 171±28.5 | 0.71 |
| QRS duration, ms | 90.5±9.7 | 94±11.1 | 0.7 |
| QT interval, ms | 384.1±14.3 | 386±11.6 | 0.37 |
| QTc interval, ms | 406.4±20.6 | 417.4±24.7 | 0.34 |
| Tp-e, ms | 67.3±15.9 | 68.8±16.1 | 0.5 |
| cTp-e, ms | 69.3±16.8 | 71.2±15.9 | 0.53 |
| Tp-e/QT | 0.17±0.03 | 0.18±0.02 | 0.45 |
| Tp-e/QTc | 0.16±0.02 | 0.17±0.03 | 0.36 |
BP - blood pressure; bmp - beats/minute; ms - milliseconds; Tp-e - distance between the peak and the end of the T wave
In this study, single low-dose Red Bull ED consumption did not acutely affect ventricular repolarization as assessed using the Tp-e and cTp-e intervals and the Tp-e/QTc ratio. It also did not affect other conventional electrocardiographic parameters, such as the PR, QRS, QT, and QTc intervals. The heart rate and mean SBP and DBP increased 1-2 h after ED ingestion.
“Energy drinks” are beverages that contain caffeine, taurine, vitamins, herbal supplements, and sugar or sweeteners, and they are marketed to improve energy, weight loss, stamina, athletic performance, and concentration (16). EDs contain 3-4-fold the amount of caffeine in a typical soda and may boost performance and enhance metabolism. Caffeine is a well-known and commonly used neurostimulant. The mechanism of action is believed to be direct adenosine receptor stimulation in addition to the effects on monoamine neurotransmitters. Caffeine is a potent stimulant, particularly at high doses (17, 18). It binds to the G-protein-coupled receptors on the surface of cardiac myocytes, ultimately leading to a rise in intracellular cyclic AMP and calcium concentrations, mimicking the chronotropic and inotropic effects of adrenaline (18, 19). Caffeine may also enhance the inotropic effect of ß-adrenergic agents. It has been shown to directly stimulate cardiac function while dilating blood vessels and appears to increase blood pressure in humans (7, 8). Documented adverse cardiovascular effects include tachycardia, extrasystoles, increased stroke volume, and possibly other arrhythmias (3, 20). In some cases, caffeine is believed to precipitate serious adverse events such as myocardial infarction and cardiac arrest. In addition, EDs contain high doses of taurine, inositol, and glucuronolactone. High doses of taurine shorten the duration of the action potential and decelerate the rate of terminal repolarization of the cardiac action potential, promoting atrial and ventricular arrhythmias or cardiac arrest (15, 21).
Previous studies have evaluated changes in electrocardiographic variables after caffeine consumption. Ammar et al. (22) observed that moderate caffeine consumption by healthy young adults does not affect the PR, QRS, QT, QTc, or RR intervals or the QT or QTc interval dispersion. The effect of caffeine (1 mg/kg of body weight) on the cardiac rhythm was investigated by Sutherland et al. (23) who reported no QT interval prolongation. Steinke et al. (24) determined the cardiac effects of 500 mL of ED daily (80 mg of caffeine) in 15 healthy volunteers and found no significant electrocardiographic changes. In accordance with previous studies, we found that consumption of Red Bull ED did not alter the PR, QRS, QT, or QTc intervals. In addition, we investigated ventricular repolarization using the Tp-e interval and Tp-e/QTc ratio. Many studies have reported that an increased dispersion of repolarization may result in predisposition to the development of ventricular arrhythmias. Siciouri et al. (25) reported an association between ventricular arrhythmias and the Tp-e interval. The duration of the action potential is longer in the middle myocardial M cells than in other myocardial cells. The peak of the T wave represents the end of the epicardial action potential, and the end of the T wave represents the end of the mid-myocardial action potential. Therefore, the Tp-e interval is a reflection of the dispersion of repolarization and can be helpful in predicting the risk of development of life-threatening arrhythmias (13). Evidence in support of this hypothesis has been provided by studies of patients with hypertrophic cardiomyopathy (26), long QT syndrome (27), Brugada syndrome (28), and other pathophysiological conditions. We evaluated the acute effects of ED consumption on the Tp-e interval and Tp-e/QT ratio and found no significant changes in either. In light of these limited results, EDs do not appear to have a significant unfavorable acute influence on left ventricular repolarization at low doses. Sovaca et al. (29, 30) performed 2 prospective studies and demonstrated that caffeine intake is significantly correlated with elevated daytime SBP and DBF! In accordance with these results, we found that SBP DBF? and heart rate were significantly increased after Red Bull ED consumption.
Study limitations
This study was limited by the relatively small number of subjects. We evaluated only the effects of low-dose ED consumption. At higher doses, the results may be different. The Tp-e measurement method may have influenced our results. Conducting more frequent blood pressure measurements and serial ECGs to identify the timing of the greatest change in blood pressure and each electrocardiographic parameter may provide additional insights. Furthermore, our results are limited to healthy subjects and require confirmation in other more vulnerable cohorts, such as those with cardiovascular risk factors.
Conclusion
We conclude that although Red Bull ED acutely increases the heart rate, SBP and DBP it does not appear to have a significant unfavorable acute influence on left ventricular repolarization as assessed by the Tp-e interval and Tp-e/QTc ratio at low doses. Further studies should aim to identify possible cardiovascular effects of EDs at higher doses.
Footnotes
Conflict of interest: None declared.
Peer-review: Externally peer-reviewed.
Authorship contributions: Concept - H.O., F.Ö., A.E., A. A.; Design - F.Ö., H.O.; Supervision - FÖ., H.O.; Resource - F.Ö., H.O.; Materials - S.S., Y.P, M.B. A., Ö.S.B., H.P; Data collection &/or processing - R.S., C.P; Analysis &/or interpretation - FÖ., H.O.; Literature search - M. A., FÖ., A.E.; Writing - FÖ., M. A.; Critical review - H.O.
References
- 1.Hoffman JR, Faigenbaum AD, Ratamess NA, Ross R, Kang J, Tenenbaum G. Nutritional supplementation and anabolic steroid use in adolescents. Med Sci Sports Exerc. 2008;40:15–24. doi: 10.1249/mss.0b013e31815a5181. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 2.Higgins JP, Tuttle TD, Higgins CL. Energy beverages: content and safety. Mayo Clin Proc. 2010;85:1033–41. doi: 10.4065/mcp.2010.0381. [CrossRef] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Goldfarb M, Tellier C, Thanassoulis G. Review of published cases of adverse cardiovascular events after ingestion of energy drinks. Am J Cardiol. 2014;113:168–72. doi: 10.1016/j.amjcard.2013.08.058. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 4.Adverse event reports allegedly related to 5-Hour Energy, Monster and Rockstar. US Food and Drug Administration. [Accessed on March 1 2013]. Available at: http://www.fda.gov/Food/NewsEvents/ucm32⅘.htm .
- 5.Gunja N, Brown JA. Energy drinks: health risks and toxicity. Med J Aust. 2012;196:46–9. doi: 10.5694/mja11.10838. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 6.Jones G. Caffeine and other sympathomimetic stimulants: modes of action and effects on sports performance. Essays Biochem. 2008;44:109–23. doi: 10.1042/BSE0440109. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 7.Myers MG. Effects of caffeine on blood pressure. Arch Intern Med. 1998;37:29–33. [PubMed] [Google Scholar]
- 8.Whitsett TL, Manion CV, Christensen HD. Cardiovascular effects of coffee and caffeine. Am J Cardiol. 1984;53:918–22. doi: 10.1016/0002-9149(84)90525-3. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 9.Satoh H. Cardiac actions of taurine as a modulator of the ion channels. Adv Exp Med Biol. 1998;442:121–8. doi: 10.1007/978-1-4899-0117-0_16. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 10.McBride BF, Karapanos AK, Krudysz A, Kluger J, Coleman CI, White CM. Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine. JAMA. 2014;291:216–21. doi: 10.1001/jama.291.2.216. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 12.Worthley MI, Prabhu A, De Sciscio PSchultz C, Sanders IP, Willoughby SR. Detrimental effects of energy drink consumption on platelet and endothelial function. Am J Med. 2010;123:184–7. doi: 10.1016/j.amjmed.2009.09.013. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 13.Higgins JFF, Babu KM. Caffeine reduces myocardial blood flow during exercise. Am J Med. 2013;126:731–8. doi: 10.1016/j.amjmed.2012.12.023. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 14.MacCornack FA. The effects of coffee drinking on the cardiovascular system: experimental and epidemiological research. Prev Med. 1977;6:104–19. doi: 10.1016/0091-7435(77)90008-1. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 15.Kors JA, Ritsema van Eck HJ, van Herpen G. The meaning of the Tp-Te interval and its diagnostic value. J Electrocardiol. 2008;41:575–80. doi: 10.1016/j.jelectrocard.2008.07.030. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 16.Morin DIP, Saad MN, Shams OF, Owen JS, Xue JQ, Abi-Samra FM, et al. Relationships between the T-peak to T-end interval, ventricular tachyarrhythmia, and death in left ventricular systolic dysfunction. Europace. 2012;14:1172–9. doi: 10.1093/europace/eur426. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 17.Seifert SM, Schaechter JL, Hershorin ER, Lipshultz SE. Health effects of energy drinks on children, adolescents, and young adults. Pediatrics. 2011;127:511–28. doi: 10.1542/peds.2009-3592. [CrossRef] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Benowitz NL, Osterloh J, Goldschlager N, Kaysen G, Pond S, Forhan S. Massive catecholamine release from caffeine positioning. JAMA. 1982;248:1097–98. [CrossRef] [PubMed] [Google Scholar]
- 19.Cannon ME, Cooke CT, McCarthy JS. Caffeine-induced cardiac arrhythmia: an unrecognized danger of healthfood products. Med J Aust. 2001;174:520–1. doi: 10.5694/j.1326-5377.2001.tb143404.x. [DOI] [PubMed] [Google Scholar]
- 20.Myers MG. Caffeine and cardiac arrhythmias. Ann Intern Med. 1991;114:147–50. doi: 10.7326/0003-4819-114-2-147. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 21.Dobmeyer DJ, Stine RA, Leier CV, Greenberg R, Schaal SF. The arrhythmogenic effects of caffeine in human beings. N Engl J Med. 1983;308:814–6. doi: 10.1056/NEJM198304073081405. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 22.Read WO, Byrne JE. Effect of taurine on the refractory period of heart muscle. Physiologist. 1966;9:273. [Google Scholar]
- 23.Ammar R, Song JC, Kluger J, White CM. Evaluation of electrocardiographic and hemodynamic effects of caffeine with acute dosing in healthy volunteers. Pharmacotherapy. 2001;21:437–42. doi: 10.1592/phco.21.5.437.34502. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 24.Sutherland DJ, McPherson DD, Renton KW, Spencer CA, Montague TJ. The effect of caffeine on cardiac rate, rhythm, and ventricular repolarization. Analysis of 18 normal subjects and 18 patients with primary ventricular dysrhythmia. Chest. 1985;87:319–24. doi: 10.1378/chest.87.3.319. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 25.Steinke L, Lanfear DE, Dhanapal V, Kalus JS. Effect of “energy drink” consumption on hemodynamic and electrocardiographic parameters in healthy young adults. Ann Pharmacother. 2009;43:596–602. doi: 10.1345/aph.1L614. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 26.Sicouri S, Antzelevitch C. A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle. The M cell. Circ Res. 1991;68:1729–41. doi: 10.1161/01.res.68.6.1729. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 27.Shimizu M, Ino H, Okeie K, Yamaguchi M, Nagata M, Hayashi K. T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion. Clin Cardiol. 2002;25:335–9. doi: 10.1002/clc.4950250706. [CrossRef] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Lubinski A, Lewicka-Nowak E, Kempa M, Baczynska AM, Romanowska I, Swiatecka G. New insight into repolarization abnormalities in patients with congenital long QT syndrome: the increased transmural dispersion of repolarization. Pacing Clin Electrophysiol. 1998;21:172–5. doi: 10.1111/j.1540-8159.1998.tb01083.x. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 29.Castro Hevia J, Antzelevitch C, Tornés Bárzaga IF, Dorantes Sánchez M, Dorticós Balea F, Zayas Molina R. Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventricular fibrillation in patients with the Brugada syndrome. J Am Coll Cardiol. 2006;47:1828–34. doi: 10.1016/j.jacc.2005.12.049. [CrossRef] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Savoca MR, MacKey ML, Evans CD, Wilson M, Ludwig DA, Harshfield GA. Association of ambulatory blood pressure and dietary caffeine in adolescents. Am J Hypertens. 2005;18:116–20. doi: 10.1016/j.amjhyper.2004.08.011. [CrossRef] [DOI] [PubMed] [Google Scholar]
- 31.Savoca MR, Evans CD, Wilson ME, Harshfield GA, Ludwig DA. The association of caffeinated beverages with blood pressure in adolescents. Arch Pediatr Adolesc Med. 2004;158:473–7. doi: 10.1001/archpedi.158.5.473. [CrossRef] [DOI] [PubMed] [Google Scholar]
